By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies this week said that the United States-Latin American Cancer Research Network (US-LACRN) will use its microarray tools and associated products for a study of breast cancer in five Latin American nations. US-LACRN is a collaboration between the US' National Cancer Institute and the ministries of health in Mexico, Brazil, Argentina, Chile, and Uruguay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.